FTC hits stalemate on PBM probe
The Commission deadlocked along party lines Thursday on whether to launch a study of the U.S.’ biggest pharmacy benefit managers.
Stay updated with breaking news from Mark Mcclellan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Commission deadlocked along party lines Thursday on whether to launch a study of the U.S.’ biggest pharmacy benefit managers.
As a virus-weary world limps through the third year of the COVID-19 pandemic, experts are sending out a warning signal: Do not expect the Omicron variant of SARS-CoV-2 to be the last variant we contend with — and do not let your guard down yet. In the midst of a vast wave of milder infections, countries around the world are dialing back restrictions and softening their messaging. Many people are starting to assume they have had their run-in with COVID-19 and that the pandemic is tailing off. That is not necessarily the case. The crisis is not over until it is over everywhere.
Food industry news, voices and jobs. Optimized for your mobile phone.
Rob Califf returns to lead the FDA as the US continues to cope with the pandemic and opioid epidemic. The agency also is facing questions about its processes for accelerated drug approvals.